Cargando…
Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
Recent network meta-analyses support the use of pharmacotherapy in patients with generalised anxiety disorder (GAD). Compared with placebo, drug treatment can improve symptoms and quality of life, and is more effective in preventing relapse. Selective serotonin reuptake inhibitors and serotonin–nore...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437845/ https://www.ncbi.nlm.nih.gov/pubmed/34417992 http://dx.doi.org/10.1007/s12325-021-01860-1 |